Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease von Egan, Michael F, Kost, James, Tariot, Pierre N, Aisen, Paul S, Cummings, Jeffrey L, Vellas, Bruno, Sur, Cyrille, Mukai, Yuki, Voss, Tiffini, Furtek, Christine, Mahoney, Erin, Harper Mozley, Lyn, Vandenberghe, Rik, Mo, Yi, Michelson, David

Volltext

Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease von Egan, Michael F, Kost, James, Voss, Tiffini, Mukai, Yuki, Aisen, Paul S, Cummings, Jeffrey L, Tariot, Pierre N, Vellas, Bruno, van Dyck, Christopher H, Boada, Merce, Zhang, Ying, Li, Wen, Furtek, Christine, Mahoney, Erin, Harper Mozley, Lyn, Mo, Yi, Sur, Cyrille, Michelson, David

Volltext

Striatal Dopamine Transporters and Cognitive Functioning in Healthy Men and Women von Mozley, Lyn Harper, Gur, Ruben C., Mozley, P. David, Gur, Raquel E.

Volltext

Long-Term Open-Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs von Hewitt, David J., Pearlman, Eric, Hämäläinen, Mirja, Lewis, Donald, Connor, Kathryn M., Michelson, David, Ceesay, Paulette, Assaid, Christopher, Bachman, Robert, Harper Mozley, Lyn, Dupre, Nicole, Strickler, Nancy, Mahoney, Erin, Lines, Christopher, Ho, Tony W.

Volltext

Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women von Gardiner, Sara A, Morrison, Mary F, Mozley, P David, Mozley, Lyn Harper, Brensinger, Colleen, Bilker, Warren, Newberg, Andrew, Battistini, Michelle

Volltext

Sex Differences in Regional Cerebral Glucose Metabolism During a Resting State von Gur, Ruben C., Mozley, Lyn Harper, Mozley, P. David, Resnick, Susan M., Karp, Joel S., Alavi, Abass, Arnold, Steven E., Gur, Raquel E.

Volltext

Relationship between clock-drawing and neuropsychological and functional status in elderly institutionalized patients with schizophrenia von Lowery, Natasha, Giovanni, Lauren, Mozley, Lyn Harper, Arnold, Steven E, Bilker, Warren B, Gur, Raquel E, Moberg, Paul J

Volltext

Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia von F. Egan, Michael, Zhao, Xin, Gottwald, Regina, Harper-Mozley, Lyn, Zhang, Ying, Snavely, Duane, Lines, Christopher, Michelson, David

Volltext

Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease von Wessels, Alette M., Lines, Christopher, Stern, Robert A., Kost, James, Voss, Tiffini, Mozley, Lyn Harper, Furtek, Christine, Mukai, Yuki, Aisen, Paul S., Cummings, Jeffrey L., Tariot, Pierre N., Vellas, Bruno, Dupre, Nicole, Randolph, Christopher, Michelson, David, Andersen, Scott W., Shering, Craig, Sims, John R., Egan, Michael F.

Volltext

Cognitive impairment and functional status in elderly institutionalized patients with schizophrenia von Kurtz, Matthew M., Moberg, Paul J., Mozley, Lyn Harper, Hickey, Thomas, Arnold, Steven E., Bilker, Warren B., Gur, Raquel E.

Volltext

Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design von Ho, Tony W, Pearlman, Eric, Lewis, Donald, Hämäläinen, Mirja, Connor, Kathryn, Michelson, David, Zhang, Ying, Assaid, Christopher, Mozley, Lyn Harper, Strickler, Nancy, Bachman, Robert, Mahoney, Erin, Lines, Christopher, Hewitt, David J

Volltext

Vulnerability to tardive dyskinesia development in schizophrenia: An FDG-PET study of cerebral metabolism von Szymanski, Sally, Gur, Ruben C., Gallacher, Fiona, Harper Mozley, Lyn, Gur, Raquel E.

Volltext

ASSESSING GEOGRAPHIC VARIABILITY IN COGNITIVE AND FUNCTIONAL BASELINE SCORES IN A LARGE MULTINATIONAL TRIAL OF MILD-TO-MODERATE ALZHEIMER’S DISEASE von Marsico, Mark, Kost, James, Mozley, Lyn Harper, Voss, Tiffini, Li, Wen, Egan, Michael, Chandler, Julie

Volltext

P2‐318: Assessing Geographic Variability in Cognitive and Functional Baseline Scores in a Large Multinational Trial of Mild‐to‐Moderate Alzheimer's Disease von Marsico, Mark, Kost, James, Mozley, Lyn Harper, Voss, Tiffini, Li, Wen, Egan, Michael, Chandler, Julie

Volltext

FTS3‐01‐05: FURTHER ANALYSES OF COGNITIVE OUTCOMES IN THE APECS PHASE‐3 TRIAL OF VERUBECESTAT IN PRODROMAL AD von Egan, Michael F., Kost, James, Lines, Christopher, Voss, Tiffini, Mozley, Lyn Harper, Furtek, Christine, Mukai, Yuki, Aisen, Paul S., Cummings, Jeffrey L., Tariot, Pierre N., Vellas, Bruno, Dupre, Nicole, Randolph, Christopher, Sur, Cyrille, Michelson, David

Volltext

FURTHER ANALYSES OF COGNITIVE OUTCOMES IN THE APECS PHASE-3 TRIAL OF VERUBECESTAT IN PRODROMAL AD von Egan, Michael F., Kost, James, Lines, Christopher, Voss, Tiffini, Mozley, Lyn Harper, Furtek, Christine, Mukai, Yuki, Aisen, Paul S., Cummings, Jeffrey L., Tariot, Pierre N., Vellas, Bruno, Dupre, Nicole, Randolph, Christopher, Sur, Cyrille, Michelson, David

Volltext

POPULATION CHARACTERIZATION IN THE EARLY STAGES OF ALZHEIMER'S DISEASE von Logovinsky, Veronika, Wessels, Alette M, Novak, Gerald, Do, Ira, Chandler, Julie, Harper-Mozley, Lyn, Rabe, Martin, Raghavan, Nandini, Luthman, Per Johan

Volltext

F4‐03‐01: POPULATION CHARACTERIZATION IN THE EARLY STAGES OF ALZHEIMER'S DISEASE von Logovinsky, Veronika, Wessels, Alette M., Novak, Gerald, Do, Ira, Chandler, Julie, Harper‐Mozley, Lyn, Rabe, Martin, Raghavan, Nandini, Luthman, Per Johan

Volltext

P4‐013: DESIGN OF A PHASE‐3 TRIAL (APECS) TO EVALUATE THE BACE INHIBITOR VERUBECESTAT IN PRODROMAL AD von Egan, Mike F., Voss, Tiffini, Kost, James, Tariot, Pierre N., Aisen, Paul S., Cummings, Jeffrey L., Vellas, Bruno, Dyck, Christopher H., Sur, Cyrille, Mukai, Yuki, Furtek, Christine, Mahoney, Erin M., Mozley, Lyn Harper, Mo, Yi, Michelson, David

Volltext

ASSESSING THE IMPACT OF A CENTRALIZED DATA REVIEW ON THE RELIABILITY OF THE ALZHEIMER’S DISEASE ASSESSMENT SCALE-COGNITIVE (ADAS-COG) von Khan, Anzalee, Atkins, Alexandra S, Stroescu, Ioan, Davis, Vicki, Williamson, Tiffany, Mozley, Lyn Harper, Voss, Tiffini, McMahon, Kerry Budd, Keefe, Richard SE

Volltext